Search Result
Results for "
L-Cysteine
" in MedChemExpress (MCE) Product Catalog:
5
Biochemical Assay Reagents
40
Isotope-Labeled Compounds
Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-Y0337
-
Cysteine
|
Endogenous Metabolite
ERK
|
Neurological Disease
Metabolic Disease
Cancer
|
L-Cysteine (Cysteine) is an orally active conditionally essential amino acid with hypoglycemic effects, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine promotes the proliferation and differentiation of neural stem cells via the CBS/H2S pathway. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans. L-Cysteine can be used as an anorectic agent .
|
-
-
- HY-W016715
-
|
Endogenous Metabolite
NF-κB
Insulin Receptor
|
Neurological Disease
Metabolic Disease
|
L-Cysteine hydrochloride hydrate is an orally active and essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine hydrochloride hydrate regulates CBS/H2S pathway, inhibits NF-κB activation and insulin and ghrelin secretion. L-Cysteine hydrochloride hydrate reduces blood sugar, vascular inflammation markers and appetite. L-Cysteine hydrochloride hydrate induces kidney damage. L-Cysteine hydrochloride hydrate can be used in the study of neurological diseases and diabetes .
|
-
-
- HY-Y0337A
-
|
Endogenous Metabolite
|
Metabolic Disease
Cancer
|
L-Cysteine hydrochloride is an orally active conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine hydrochloride suppresses ghrelin and reduces appetite in rodents. L-Cysteine hydrochloride inhibits Aspergillus flavus growth and AFB synthesis by disrupting cell structure and antioxidant system balance. L-Cysteine hydrochloride enhances relaxant responses of rat aortic rings to NO and reduces responses to endothelium-derived relaxing factor (EDRF) .
|
-
-
- HY-W016715R
-
|
Reference Standards
Endogenous Metabolite
|
Metabolic Disease
|
L-Cysteine (hydrochloride hydrate) (Standard) is the analytical standard of L-Cysteine (hydrochloride hydrate). This product is intended for research and analytical applications. L-Cysteine hydrochloride hydrate is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine hydrochloride hydrate suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-B1038
-
|
Endogenous Metabolite
|
Inflammation/Immunology
|
L-Cysteine methyl ester hydrochloride is an antitussive, phlegmolytic agent used to relieve breathing difficulties caused by large amounts of phlegm. L-Cysteine methyl ester hydrochloride is a copper corrosion inhibitor used in various industrial studies .
|
-
-
- HY-45609
-
|
iGluR
Endogenous Metabolite
|
Neurological Disease
|
L-Cysteine S-sulfate sodium hydrate is a potent N-methyl-d-aspartate (NMDA) glutamatergic receptors agonist. L-Cysteine S-sulfate sodium hydrate is the substrate for cystine lyase, it can be used in mass spectrometry operations .
|
-
-
- HY-Y0337R
-
Cysteine (Standard)
|
Reference Standards
Endogenous Metabolite
|
Metabolic Disease
Cancer
|
L-Cysteine (Standard) is the analytical standard of L-Cysteine. This product is intended for research and analytical applications. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337AR
-
|
Reference Standards
Endogenous Metabolite
|
Metabolic Disease
Cancer
|
L-Cysteine (hydrochloride) (Standard) is the analytical standard of L-Cysteine (hydrochloride). This product is intended for research and analytical applications. L-Cysteine hydrochloride is an orally active conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine hydrochloride suppresses ghrelin and reduces appetite in rodents. L-Cysteine hydrochloride inhibits Aspergillus flavus growth and AFB synthesis by disrupting cell structure and antioxidant system balance. L-Cysteine hydrochloride enhances relaxant responses of rat aortic rings to NO and reduces responses to endothelium-derived relaxing factor (EDRF) [4].
|
-
-
- HY-100787
-
|
iGluR
Endogenous Metabolite
|
Neurological Disease
|
L-Cysteine S-sulfate sodium is a potent N-methyl-d-aspartate (NMDA) glutamatergic receptors agonist. L-Cysteine S-sulfate sodium hydrate is the substrate for cystine lyase, it can be used in mass spectrometry operations .
|
-
-
- HY-113084
-
|
iGluR
Endogenous Metabolite
|
Neurological Disease
|
L-Cysteine S-sulfate is a potent N-methyl-d-aspartate (NMDA) glutamatergic receptor agonist. L-Cysteine S-sulfate is the substrate for cystine lyase, and can be used in mass spectrometry operations .
|
-
-
- HY-45609R
-
|
iGluR
Endogenous Metabolite
|
Neurological Disease
|
L-Cysteine S-sulfate (sodium hydrate) (Standard) is the analytical standard of L-Cysteine S-sulfate (sodium hydrate). This product is intended for research and analytical applications. L-Cysteine S-sulfate sodium hydrate is a potent N-methyl-d-aspartate (NMDA) glutamatergic receptors agonist. L-Cysteine S-sulfate sodium hydrate is the substrate for cystine lyase, it can be used in mass spectrometry operations .
|
-
-
- HY-Y1875
-
-
-
- HY-Y0337S5
-
|
Isotope-Labeled Compounds
Endogenous Metabolite
|
Metabolic Disease
|
L-Cysteine-d3 is the deuterium labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S6
-
|
Isotope-Labeled Compounds
Endogenous Metabolite
|
Metabolic Disease
|
L-Cysteine-d2 is the deuterium labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S1
-
|
Endogenous Metabolite
|
Metabolic Disease
|
L-Cysteine- 15N is the 15N-labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S4
-
|
Endogenous Metabolite
|
Metabolic Disease
|
L-Cysteine- 13C3 is the 13C-labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S2
-
|
Endogenous Metabolite
|
Metabolic Disease
|
L-Cysteine-3- 13C is the 13C-labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S3
-
|
Endogenous Metabolite
|
Metabolic Disease
|
L-Cysteine-1- 13C is the 13C-labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S7
-
|
Isotope-Labeled Compounds
Endogenous Metabolite
|
Metabolic Disease
|
L-Cysteine-d3, 15N is the deuterium and 15N-labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S
-
|
Endogenous Metabolite
|
Metabolic Disease
|
L-Cysteine- 13C3, 15N is the 13C- and 15N-labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-N0771S6
-
-
-
- HY-CE01659
-
-
-
- HY-135174
-
|
Endogenous Metabolite
|
Infection
|
L-Cysteine-glutathione disulfide is a metabolite in plasma that can be used in biomarker studies for tuberculosis cure .
|
-
-
- HY-N15761
-
-
-
- HY-CE01785
-
-
-
- HY-W425671
-
-
-
- HY-W009682
-
-
-
- HY-W013573
-
-
-
- HY-118642
-
|
Cholinesterase (ChE)
Reactive Oxygen Species (ROS)
|
Cardiovascular Disease
Neurological Disease
|
D-Ribose-L-cysteine is an orally active cysteine analog. D-Ribose-L-cysteine improves cellular antioxidant capacity by enhancing intracellular glutathione (GSH) biosynthesis. In addition, D-Ribose-L-cysteine has a memory-enhancing effect and can reverse Scopolamine (HY-N0296)-induced memory impairment by inhibiting oxidative stress and acetylcholinesterase (AChE) activity. D-Ribose-L-cysteine can be used in the study of neurodegenerative and cardiovascular diseases .
|
-
-
- HY-128466
-
|
Biochemical Assay Reagents
|
Others
|
N-Biotinyl-L-cysteine is a biotinylated biochemical assay reagent, which is used to detect avidin and biotin through a competitive binding reaction .
|
-
-
- HY-W141791
-
-
-
- HY-W554799
-
-
-
- HY-W013573R
-
-
-
- HY-114788
-
-
-
- HY-111827
-
-
-
- HY-W014238
-
-
-
- HY-B2188R
-
|
Reactive Oxygen Species (ROS)
|
Neurological Disease
Metabolic Disease
|
S-Methyl-L-cysteine (Standard) is the analytical standard of S-Methyl-L-cysteine. This product is intended for research and analytical applications. S-Methyl-L-cysteine is a natural product that acts as a substrate in the catalytic antioxidant system mediated by methionine sulfoxide reductase A (MSRA), with antioxidative, neuroprotective, and anti-obesity activities.
|
-
-
- HY-111592
-
-
-
- HY-W587485
-
|
Drug Metabolite
|
Others
|
N-acetyl-S-(trichlorovinyl)-L-cysteine is a metabolite of the volatile organic compound (VOC) .
|
-
-
- HY-160255
-
Cbz-Cysteine
|
Beta-lactamase
|
Infection
|
N-Cbz-L-Cysteine (Cbz-cysteine) (compound 5) is a potent β-lactamase II inhibitor with a Ki value of 97 µM .
|
-
-
- HY-111827R
-
|
Histamine Receptor
|
Cardiovascular Disease
Others
Metabolic Disease
Inflammation/Immunology
|
S-1-Propenyl-L-cysteine (Standard) is the analytical standard of S-1-Propenyl-L-cysteine. This product is intended for research and analytical applications. S-1-Propenyl-L-cysteine is a stereoisomer of S-allyl-l-cysteine, extracted from garlic, with immunomodulatory effects and reduces blood pressure in a hypertensive animal model . S-1-Propenyl-L-cysteine exhibits antioxidative efficacy through a NO-dependent BACH1 signaling pathway . S-1-Propenyl-L-cysteine is orally active.
|
-
-
- HY-121765
-
N,S-Diacetyl-L-Cysteine
|
Endogenous Metabolite
|
Metabolic Disease
|
Dacisteine (N,S-Diacetyl-L-cysteine) is a cysteine derivative and displays a less New Delhi metallo-beta-lactamase-1 (NDM-1) inhibitor with an IC50 value of 1000 μM . Dacisteine can be used for the treatment of cardiovascular and cerebrovascular diseases caused by platelet aggregation .
|
-
-
- HY-W142867
-
-
-
- HY-W588247
-
SF-Cysteine
|
Drug Metabolite
|
Cancer
|
S-(N-Methylsulfinylbutylthiocarbamoyl)-L-cysteine (SF-cysteine), a metabolite of Sulforaphane (HY-13755), can enhance the survival rate of Nalm-6 cells .
|
-
-
- HY-115754
-
PEITC-Cys
|
DNA/RNA Synthesis
Cytochrome P450
|
Cancer
|
S-(N-PhenethylthiocarbaMoyl)-L-cysteine (PEITC-Cys), an anticarcinogenic agent, has antileukemic activity. S-(N-PhenethylthiocarbaMoyl)-L-cysteine inhibits DNA synthesis in HL60 cells . S-(N-PhenethylthiocarbaMoyl)-L-cysteine is a P450 inhibitor .
|
-
-
- HY-W141774
-
S-CarboxyethylCysteine
|
Amino Acid Derivatives
|
Metabolic Disease
|
S-(2-Carboxyethyl)-L-cysteine (S-Carboxyethylcysteine) is a non-protein (modified) sulfur amino acid. S-(2-Carboxyethyl)-L-cysteine is present in Acacia seed. S-(2-Carboxyethyl)-L-cysteine can affect the seed’s protein use in rats. S-(2-Carboxyethyl)-L-cysteine suppresses the methionine-induced growth rate, and has a negative effect on the plasma amino acid levels in rats .
|
-
-
- HY-111592S
-
-
-
- HY-114788A
-
L-Lysyl-L-Cysteine TFA
|
Amino Acid Derivatives
|
Others
|
Lysylcysteine (L-Lysyl-L-cysteine) TFA is a dipeptide composed of lysine and cysteine .
|
-
-
- HY-B2188
-
-
-
- HY-W004153
-
-
- HY-133021
-
N-Acetyl-S-farnesyl-L-Cysteine
|
DNA Methyltransferase
|
Inflammation/Immunology
|
Arazine (N-Acetyl-S-farnesyl-L-cysteine) is a cell-permeable modulator of G protein and G-protein coupled receptor signaling. Arazine can be a a substrate for isoprenylcysteine methyltransferase by competing with prenylated G protein or its receptors site .
|
-
- HY-114245B
-
MethylselenoCysteine hydrochloride; Se-Methylseleno-L-Cysteine hydrochloride
|
Endogenous Metabolite
Apoptosis
Beta-secretase
|
Cancer
|
Se-Methylselenocysteine hydrochloride, a precursor of Methylselenol, has potent cancer chemopreventive activity and anti-oxidant activity. Se-Methylselenocysteine hydrochloride is orally bioavailable, and induces apoptosis .
|
-
- HY-139137
-
AGGC
|
DNA Methyltransferase
Integrin
|
Cancer
|
N-Acetyl-S-geranylgeranyl-L-cysteine is a Methyltransferase inhibitor. N-Acetyl-S-geranylgeranyl-L-cysteine inhibits beta 2 integrin-induced actin polymerization with an IC50 of 45 nM .
|
-
- HY-114245
-
MethylselenoCysteine; Se-Methylseleno-L-Cysteine
|
Apoptosis
Endogenous Metabolite
Beta-secretase
|
Cancer
|
Se-Methylselenocysteine, a precursor of Methylselenol, has potent cancer chemopreventive activity and anti-oxidant activity. Se-Methylselenocysteine is orally bioavailable, and induces apoptosis .
|
-
- HY-N10123
-
-
- HY-147065
-
|
Others
|
Others
|
γ-L-Glutamyl-S-allyl-L-cysteine is a naturally occurring organosulfur compound found in garlic .
|
-
- HY-139474S
-
-
- HY-W214059S
-
-
- HY-121765R
-
N,S-Diacetyl-L-Cysteine (Standard)
|
Reference Standards
Endogenous Metabolite
|
Metabolic Disease
|
Dacisteine (Standard) is the analytical standard of Dacisteine. This product is intended for research and analytical applications. Dacisteine (N,S-Diacetyl-L-cysteine) is a cysteine derivative and displays a less New Delhi metallo-beta-lactamase-1 (NDM-1) inhibitor with an IC50 value of 1000 μM . Dacisteine can be used for the treatment of cardiovascular and cerebrovascular diseases caused by platelet aggregation .
|
-
- HY-W101367S
-
-
- HY-W141770
-
-
- HY-W560593
-
-
- HY-B0215
-
Acetylcysteine
Maximum Cited Publications
538 Publications Verification
N-AcetylCysteine; N-Acetyl-L-Cysteine; NAC
|
Reactive Oxygen Species (ROS)
Endogenous Metabolite
Apoptosis
Ferroptosis
Influenza Virus
Disulfidptosis
|
Infection
Neurological Disease
Cancer
|
Acetylcysteine (N-Acetylcysteine) is a mucolytic agent which reduces the thickness of the mucus. Acetylcysteine is a ROS inhibitor. Acetylcysteine is a cysteine precursor, prevents hemin-induced ferroptosis by neutralizing toxic lipids generated by arachidonate-dependent activity of 5-lipoxygenases. Acetylcysteine induces cell apoptosis. Acetylcysteine also has anti-influenza virus activities. In addition, Acetylcysteine is the most stable form of cysteine during drug delivery and can be used in disulfidptosis studies .
|
-
- HY-144414S
-
-
- HY-144355S
-
-
- HY-141718S
-
-
- HY-132242
-
SFN-NAC
|
HDAC
Apoptosis
Drug Metabolite
|
Cancer
|
DL-Sulforaphane N-acetyl-L-cysteine (SFN-NAC) is an orally active HDAC inhibitor and metabolite of sulforaphane (HY-13755) with longer half-life and better blood-brain barrier permeability. DL-Sulforaphane N-acetyl-L-cysteine activates autophagy-mediated downregulation of α-tubulin expression through the ERK pathway and can be used in cancer research .
|
-
- HY-139491S
-
-
- HY-W251393
-
-
- HY-139474S1
-
-
- HY-134495
-
N-AcetylCysteine ethyl ester; NACET
|
Reactive Oxygen Species (ROS)
|
Metabolic Disease
|
N-Acetyl-L-cysteine ethyl ester is an esterified form of N-acetyl-L-cysteine (NAC). N-Acetyl-L-cysteine ethyl ester exhibits enhanced cell permeability, and produce NAC and cysteine. N-Acetyl-L-cysteine ethyl ester increases circulating hydrogen sulfide (H2S) and can be used as an H2S producer. N-Acetyl-L-cysteine ethyl ester has the potential to substitute NAC as a mucolytic agent, and as a GSH-related antioxidant .
|
-
- HY-144409S
-
-
- HY-144408S
-
-
- HY-144407S
-
-
- HY-W048727
-
-
- HY-19717
-
S-[(1E)-1,2-Dichloroethenyl]-L-Cysteine
|
TNF Receptor
|
Inflammation/Immunology
|
DCVC (S-[(1E)-1,2-Dichloroethenyl]-L-cysteine) is a bioactive metabolite of trichloroethylene (TCE). DCVC inhibits pathogen-stimulated pro-inflammatory cytokines IL-1β, IL-8, and TNF-α release from tissue cultures .
|
-
- HY-P4022
-
-
- HY-W714558
-
-
- HY-19570A
-
S-(1,2-Dichlorovinyl)-L-Cysteine hydrochloride
|
TNF Receptor
Drug Metabolite
|
Inflammation/Immunology
|
NSC 15830 (S-(1,2-Dichlorovinyl)-L-cysteine) hydrochloride is a nephrotoxin and metabolite of trichloroethylene. NSC 15830 hydrochloride inhibits pathogen-stimulated TNF-α .
|
-
- HY-144360S1
-
|
Isotope-Labeled Compounds
|
Others
|
N-Acetyl-S-(3,4-dimethylphenyl)-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-(3,4-dimethylphenyl)-L-cysteine (HY-W596250).
|
-
- HY-114245R
-
-
- HY-132805S
-
|
Isotope-Labeled Compounds
|
Others
|
N-Acetyl-S-(2-hydroxyethyl)-L-cysteine-d4 (dicyclohexylamine) is the deuterium labeled N-Acetyl-S-(2-hydroxyethyl)-L-cysteine dicyclohexylamine salt .
|
-
- HY-W587731S
-
-
- HY-144362S
-
-
- HY-146717S
-
|
Isotope-Labeled Compounds
|
Others
|
N-Acetyl-S-(3-hydroxypropyl)-L-cysteine-d6 (dicyclohexylamine) is the deuterium labeled N-Acetyl-S-(3-hydroxypropyl)-L-cysteine.
|
-
- HY-132242R
-
SFN-NAC (Standard)
|
Reference Standards
HDAC
Apoptosis
Drug Metabolite
|
Cancer
|
Pipemidic acid (trihydrate) (Standard) is the analytical standard of Pipemidic acid (trihydrate). This product is intended for research and analytical applications. Pipemidic acid trihydrate, a derivative of Piromidic acid, is an antibacterial agent. Pipemidic acid trihydrate inhibits DNA gyrase. Pipemidic acid trihydrate is active against gram-negative bacteria including Pseudomonas aeruginosa as well as some gram-positive bacteria. Pipemidic acid trihydrate can be used for the research of intestinal, urinary, and biliary tract infections .
|
-
- HY-W101367
-
N-Acetyl-S-benzyl-L-Cysteine; Benzylmercapturic acid
|
Drug Metabolite
|
Others
|
Ac-Cys(Bzl)-OH (N-Acetyl-S-benzyl-L-cysteine) is a toluene metabolite. Ac-Cys(Bzl)-OH in urine samples is a good marker of occupational toluene exposure.
|
-
- HY-W587741
-
Dihydroxybutyl mercapturic acid; DHBMA
|
Others
|
Others
|
N-Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (Dihydroxybutyl mercapturic acid) is a biomarkersof 1,3-butadiene exposure. 1,3-Butadiene is a known human carcinogen present in cigarette smoke and in automobile exhaust.
|
-
- HY-146716S
-
|
Isotope-Labeled Compounds
|
Others
|
N-Acetyl-S-(N-methyl-carbamoyl)-L-cysteine-d3 (dicyclohexylamine) is the deuterium labeled N-Acetyl-S-(N-methyl-carbamoyl)-L-cysteine.
|
-
- HY-111825A
-
Isoalliin; trans-(+)-S-1-Propenyl-L-Cysteine sulfoxide
|
Endogenous Metabolite
|
Others
|
(R)-1-PeCSO (trans-(+)-S-1-Propenyl-L-cysteine sulfoxide) is the most abundant flavor precursor in onions .
|
-
- HY-141719S
-
|
Isotope-Labeled Compounds
|
Others
|
N-Acetyl-S-(3-carboxy-2-propyl)-L-cysteine-d3 disodium is the deuterium labeled N-Acetyl-S-(3-carboxy-2-propyl)-L-cysteine disodium .
|
-
- HY-144367S
-
|
Isotope-Labeled Compounds
|
Others
|
N-Acetyl-S-(2-hydroxy-3-propionamide)-L-cysteine-d3 (dicyclohexylammonium) is the deuterium labeled N-Acetyl-S-(2-hydroxy-3-propionamide)-L-cysteine (dicyclohexylammonium) .
|
-
- HY-W766569
-
|
Isotope-Labeled Compounds
|
Others
|
N-Acetyl S-(1,2-dichlorovinyl)-L-cysteine- 13C,d3 is 13C and deuterated labeled N-Acetyl S-(1,2-dichlorovinyl)-L-cysteine.
|
-
- HY-W048708
-
-
- HY-B0215R
-
N-AcetylCysteine (Standard); N-Acetyl-L-Cysteine (Standard); NAC (Standard)
|
Reference Standards
Reactive Oxygen Species (ROS)
Endogenous Metabolite
Apoptosis
Ferroptosis
Influenza Virus
Disulfidptosis
|
Infection
Neurological Disease
Cancer
|
Acetylcysteine (Standard) is the analytical standard of Acetylcysteine. This product is intended for research and analytical applications. Acetylcysteine (N-Acetylcysteine) is a mucolytic agent which reduces the thickness of the mucus. Acetylcysteine is a ROS inhibitor . Acetylcysteine is a cysteine precursor, prevents hemin-induced ferroptosis by neutralizing toxic lipids generated by arachidonate-dependent activity of 5-lipoxygenases . Acetylcysteine induces cell apoptosis . Acetylcysteine also has anti-influenza virus activities . In addition, Acetylcysteine is the most stable form of cysteine during drug delivery and can be used in disulfidptosis studies .
|
-
- HY-13709
-
AV 4430A; GW 280430A
|
Biochemical Assay Reagents
|
Neurological Disease
|
Gantacurium is an ultrashort-acting, nondepolarizing neuromuscular blocking agent that is degraded by nonenzymatic binding to L-cysteine under physiological conditions. Gantacurium causes a decrease in mean arterial pressure and an increase in heart rate .
|
-
- HY-W023145
-
-
- HY-W654314
-
-
- HY-144364S
-
|
Isotope-Labeled Compounds
|
Others
|
N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine .
|
-
- HY-W009008
-
-
- HY-W009356A
-
|
Biochemical Assay Reagents
|
Others
|
L-Cystine monohydrochloride is an amino acid. L-Cystine is converted to L-Cysteine in the body. Moreover, L-Cystine/L-Cysteine conversion system is a channel on the cell membrane, which can maintain the internal REDOX homeostasis of E. coli .
|
-
- HY-W036322
-
-
- HY-W011102
-
NSC 83265; S-TritylCysteine; 3-Tritylthio-L-alanine
|
Kinesin
Apoptosis
|
Cancer
|
S-Trityl-L-cysteine (NSC 83265) is a selective and allosteric kinesin Eg5 inhibitor with an IC50 of 1 μM for the inhibition of basal ATPase activity and 140 nM for the microtubule-activated ATPase activity. S-Trityl-L-cysteine has antitumor activities .
|
-
- HY-144364S1
-
|
Isotope-Labeled Compounds
|
Others
|
cis-N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine-d3 is the deuterium labeled cis-N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine.
|
-
- HY-114976S
-
N-(Acetyl-d3)-S-allyl-L-Cysteine
|
Isotope-Labeled Compounds
|
Others
|
N-Acetyl-S-allyl-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-allyl-L-cysteine (HY-114976) .
|
-
- HY-W048681
-
-
- HY-160902
-
|
Autophagy
|
Others
|
2G-HaloAUTAC (Compound tt44) is a second-generation autophagy-targeting chimera (2G-HaloAUTAC) that improves the activity of AUTACs by replacing the L-Cysteine (L-Cys) linker with other structures. 2G-HaloAUTAC exhibits degradation activity against EGFP-HaloTag protein through an autophagic mechanism .
|
-
- HY-W770952
-
N-Acetyl-S-phenyl-L-Cysteine-13C6
|
Isotope-Labeled Compounds
Amino Acid Derivatives
|
Others
|
DL-Phenylmercapturic Acid- 13C6 (N-Acetyl-S-phenyl-L-cysteine- 13C6) is the 13C-labeled DL-Phenylmercapturic Acid (HY-W141770). DL-Phenylmercapturic Acid is a cysteine derivative .
|
-
- HY-B0215S1
-
N-AcetylCysteine-15N; N-Acetyl-L-Cysteine-15N; NAC-15N
|
Isotope-Labeled Compounds
Reactive Oxygen Species (ROS)
Endogenous Metabolite
Apoptosis
Ferroptosis
Influenza Virus
Disulfidptosis
|
Infection
Neurological Disease
|
Acetylcysteine- 15N (N-Acetylcysteine- 15N) is the 15N-labeled Acetylcysteine. Acetylcysteine (N-Acetylcysteine) is a mucolytic agent which reduces the thickness of the mucus. Acetylcysteine is a ROS inhibitor. Acetylcysteine is a cysteine precursor, prevents hemin-induced ferroptosis by neutralizing toxic lipids generated by arachidonate-dependent activity of 5-lipoxygenases. Acetylcysteine induces cell apoptosis. Acetylcysteine also has anti-influenza virus activities. In addition, Acetylcysteine is the most stable form of cysteine during drug delivery and can be used in disulfidptosis studies .
|
-
- HY-B0215S
-
N-AcetylCysteine-d3; N-Acetyl-L-Cysteine-d3; NAC-d3
|
Isotope-Labeled Compounds
Reactive Oxygen Species (ROS)
Endogenous Metabolite
Apoptosis
Ferroptosis
Influenza Virus
Disulfidptosis
|
Infection
Neurological Disease
|
Acetylcysteine-d3 is the deuterium labeled Acetylcysteine. Acetylcysteine (N-Acetylcysteine) is a mucolytic agent which reduces the thickness of the mucus. Acetylcysteine is a ROS inhibitor. Acetylcysteine is a cysteine precursor, prevents hemin-induced ferroptosis by neutralizing toxic lipids generated by arachidonate-dependent activity of 5-lipoxygenases. Acetylcysteine induces cell apoptosis. Acetylcysteine also has anti-influenza virus activities. In addition, Acetylcysteine is the most stable form of cysteine during drug delivery and can be used in disulfidptosis studies .
|
-
- HY-W721117
-
Methyl N-acetyl-S-(3-hydroxypropyl)-L-cysteinate-d3
|
Isotope-Labeled Compounds
|
Others
|
N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine-d3 (Methyl N-acetyl-S-(3-hydroxypropyl)-L-cysteinate-d3) is the deuterium labeled N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine.
|
-
- HY-19717S
-
S-[(1E)-1,2-Dichloroethenyl]-L-Cysteine-13C3,15N
|
Isotope-Labeled Compounds
|
Inflammation/Immunology
|
DCVC- 13C3, 15N is 15N and 13C labeled DCVC. DCVC (S-[(1E)-1,2-Dichloroethenyl]-L-cysteine) is a bioactive metabolite of trichloroethylene (TCE). DCVC inhibits pathogen-stimulated pro-inflammatory cytokines IL-1β, IL-8, and TNF-α release from tissue cultures .
|
-
- HY-P4895
-
|
Oxytocin Receptor
|
Neurological Disease
|
(d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin (OVT) is an oxytocin receptor antagonist. (d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin can be used for the research of neurological disease .
|
-
- HY-W009356
-
|
Endogenous Metabolite
Ferroptosis
ROS Kinase
Keap1-Nrf2
Reactive Oxygen Species (ROS)
|
Others
|
L-Cystine hydrochloride is an orally active extracellular form of L-Cysteine (HY-Y0337), occurring in proteins of plants and animals. L-Cystine hydrochloride elevates Nrf2 protein expression and activates Nrf2 transcription factor. L-Cystine hydrochloride reduces ROS generation and protects against oxidant- or Doxorubicin (HY-15142A)-induced apoptosis. L-Cystine hydrochloride combined with L-theanine (HY-15121) enhances the production of antigen-specific IgG by increasing glutathione (GSH) levels and T helper 2 (Th2) mediated responses in mice. L-Cystine hydrochloride is promising for research of cystinuria and kidney stones
|
-
- HY-N0394
-
|
Endogenous Metabolite
Ferroptosis
ROS Kinase
Keap1-Nrf2
Reactive Oxygen Species (ROS)
|
Metabolic Disease
Inflammation/Immunology
Cancer
|
L-Cystine is an orally active extracellular form of L-Cysteine (HY-Y0337), occurring in proteins of plants and animals. L-Cystine elevates Nrf2 protein expression and activates Nrf2 transcription factor. L-cystine reduces ROS generation and protects against oxidant- or Doxorubicin (HY-15142A)-induced apoptosis. L-Cystine combined with L-theanine (HY-15121) enhances the production of antigen-specific IgG by increasing glutathione (GSH) levels and T helper 2 (Th2) mediated responses in mice. L-Cystine is promising for research of cystinuria and kidney stones
|
-
- HY-N0394R
-
|
Reference Standards
Endogenous Metabolite
Ferroptosis
ROS Kinase
Keap1-Nrf2
|
Metabolic Disease
Inflammation/Immunology
Cancer
|
L-Cystine (Standard) is the analytical standard of L-Cystine. This product is intended for research and analytical applications. L-Cystine, the extracellular form of L-Cysteine (HY-Y0337), is a nutritionally dispensable semiessential sulfur-containing amino acid, occurring in proteins of plants and animals. L-Cystine induces Nrf2 protein elevation in a Keap1 (HY-P75897)-dependent manner and activates Nrf2 transcription factor. L-cystine can elicit cytoprotection by reducing ROS generation and protecting against oxidant- or doxorubicin-induced apoptosis. The reduced reabsorption of L-Cystine in renal tubules and its poor solubility in urine are the important causes of cystine precipitation and cystine crystal formation eventually leading to kidney stones. L-Cystine combined with L-theanine (HY-15121) enhances the production of antigen-specific IgG by increasing glutathione (GSH) levels and T helper 2 (Th2) mediated responses in mice. L-Cystine is promising for research of cystinuria and cystinosis
|
-
Cat. No. |
Product Name |
Type |
-
- HY-128466
-
|
Biochemical Assay Reagents
|
N-Biotinyl-L-cysteine is a biotinylated biochemical assay reagent, which is used to detect avidin and biotin through a competitive binding reaction .
|
-
- HY-W554799
-
|
Microbial Culture
|
S-Benzyl-L-cysteine ethyl ester (hydrochloride) is a kind of biochemical reagent.
|
-
- HY-W142867
-
-
- HY-W560593
-
|
Enzyme Substrates
|
S-Benzyl-L-cysteine 7-amido-4-methylcoumarin is a biochemical reagent.
|
-
- HY-W009356A
-
|
Biochemical Assay Reagents
|
L-Cystine monohydrochloride is an amino acid. L-Cystine is converted to L-Cysteine in the body. Moreover, L-Cystine/L-Cysteine conversion system is a channel on the cell membrane, which can maintain the internal REDOX homeostasis of E. coli .
|
Cat. No. |
Product Name |
Target |
Research Area |
Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
Cat. No. |
Product Name |
Chemical Structure |
-
- HY-Y0337S5
-
|
L-Cysteine-d3 is the deuterium labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S6
-
1 Publications Verification
|
L-Cysteine-d2 is the deuterium labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S1
-
1 Publications Verification
|
L-Cysteine- 15N is the 15N-labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S4
-
1 Publications Verification
|
L-Cysteine- 13C3 is the 13C-labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S2
-
|
L-Cysteine-3- 13C is the 13C-labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S3
-
|
L-Cysteine-1- 13C is the 13C-labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S
-
1 Publications Verification
|
L-Cysteine- 13C3, 15N is the 13C- and 15N-labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-Y0337S7
-
|
L-Cysteine-d3, 15N is the deuterium and 15N-labeled L-Cysteine. L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans .
|
-
-
- HY-N0771S6
-
|
L-Cysteine- 13C3, 15N,d3 is the deuterium, 13C-, and 15-labeled L-Isoleucine (HY-Y0337). L-isoleucine is a nonpolar hydrophobic amino acid . L-Isoleucine is an essential amino acid.
|
-
-
- HY-111592S
-
|
S-(5′-Adenosyl)-L-cysteine- 13C is the 13C labeled S-(5′-Adenosyl)-L-cysteine (HY-111592). S-(5′-Adenosyl)-L-cysteine is a cysteine derivative .
|
-
-
- HY-139474S
-
|
N-Acetyl-S-(carbamoylethyl)-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-(carbamoylethyl)-L-cysteine .
|
-
-
- HY-W214059S
-
|
N-Acetyl-S-methyl-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-methyl-L-cysteine .
|
-
-
- HY-W101367S
-
|
N-Acetyl-S-benzyl-L-cysteine-d5 is the deuterium labeled N-Acetyl-S-benzyl-L-cysteine.
|
-
-
- HY-144414S
-
|
N-Acetyl-S-ethyl-L-cysteine-d5 is the deuterium labeled N-Acetyl-S-ethyl-L-cysteine .
|
-
-
- HY-144355S
-
|
N-Acetyl-S-propyl-L-cysteine-d7 is the deuterium labeled N-Acetyl-S-propyl-L-cysteine.
|
-
-
- HY-141718S
-
|
N-Acetyl-S-(trichlorovinyl)-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-(trichlorovinyl)-L-cysteine .
|
-
-
- HY-139491S
-
|
N-(Acetyl-d3)-S-benzyl-L-cysteine is the deuterium labeled N-(Acetyl)-S-benzyl-L-cysteine .
|
-
-
- HY-139474S1
-
|
N-Acetyl-S-(carbamoylethyl)-L-cysteine-d4 is the deuterium labeled N-Acetyl-S-(carbamoylethyl)-L-cysteine .
|
-
-
- HY-144409S
-
|
N-Acetyl-S-(2-cyanoethyl)-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-(2-cyanoethyl)-L-cysteine .
|
-
-
- HY-144408S
-
|
N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine .
|
-
-
- HY-144407S
-
|
N-Acetyl-S-(2-carboxyethyl)-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-(2-carboxyethyl)-L-cysteine .
|
-
-
- HY-W714558
-
|
N-Acetyl-S-(2-cyanoethyl)-L-cysteine-d3 ammonium is a deuterium labeled N-Acetyl-S-(2-cyanoethyl)-L-cysteine ammonium.
|
-
-
- HY-144360S1
-
|
N-Acetyl-S-(3,4-dimethylphenyl)-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-(3,4-dimethylphenyl)-L-cysteine (HY-W596250).
|
-
-
- HY-132805S
-
|
N-Acetyl-S-(2-hydroxyethyl)-L-cysteine-d4 (dicyclohexylamine) is the deuterium labeled N-Acetyl-S-(2-hydroxyethyl)-L-cysteine dicyclohexylamine salt .
|
-
-
- HY-W587731S
-
|
N-Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine-d7 is a deuterium labeled compound.
|
-
-
- HY-144362S
-
|
N-Acetyl-S-(2,5-dimethylbenzene)-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-(2,5-dimethylbenzene)-L-cysteine .
|
-
-
- HY-146717S
-
|
N-Acetyl-S-(3-hydroxypropyl)-L-cysteine-d6 (dicyclohexylamine) is the deuterium labeled N-Acetyl-S-(3-hydroxypropyl)-L-cysteine.
|
-
-
- HY-146716S
-
|
N-Acetyl-S-(N-methyl-carbamoyl)-L-cysteine-d3 (dicyclohexylamine) is the deuterium labeled N-Acetyl-S-(N-methyl-carbamoyl)-L-cysteine.
|
-
-
- HY-141719S
-
|
N-Acetyl-S-(3-carboxy-2-propyl)-L-cysteine-d3 disodium is the deuterium labeled N-Acetyl-S-(3-carboxy-2-propyl)-L-cysteine disodium .
|
-
-
- HY-144367S
-
|
N-Acetyl-S-(2-hydroxy-3-propionamide)-L-cysteine-d3 (dicyclohexylammonium) is the deuterium labeled N-Acetyl-S-(2-hydroxy-3-propionamide)-L-cysteine (dicyclohexylammonium) .
|
-
-
- HY-W766569
-
|
N-Acetyl S-(1,2-dichlorovinyl)-L-cysteine- 13C,d3 is 13C and deuterated labeled N-Acetyl S-(1,2-dichlorovinyl)-L-cysteine.
|
-
-
- HY-W654314
-
|
S-Phenyl-d5-mercapturic Acid is deuterated labeled S-Phenyl.
|
-
-
- HY-144364S
-
|
N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine .
|
-
-
- HY-144364S1
-
|
cis-N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine-d3 is the deuterium labeled cis-N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine.
|
-
-
- HY-114976S
-
|
N-Acetyl-S-allyl-L-cysteine-d3 is the deuterium labeled N-Acetyl-S-allyl-L-cysteine (HY-114976) .
|
-
-
- HY-W770952
-
|
DL-Phenylmercapturic Acid- 13C6 (N-Acetyl-S-phenyl-L-cysteine- 13C6) is the 13C-labeled DL-Phenylmercapturic Acid (HY-W141770). DL-Phenylmercapturic Acid is a cysteine derivative .
|
-
-
- HY-B0215S1
-
|
Acetylcysteine- 15N (N-Acetylcysteine- 15N) is the 15N-labeled Acetylcysteine. Acetylcysteine (N-Acetylcysteine) is a mucolytic agent which reduces the thickness of the mucus. Acetylcysteine is a ROS inhibitor. Acetylcysteine is a cysteine precursor, prevents hemin-induced ferroptosis by neutralizing toxic lipids generated by arachidonate-dependent activity of 5-lipoxygenases. Acetylcysteine induces cell apoptosis. Acetylcysteine also has anti-influenza virus activities. In addition, Acetylcysteine is the most stable form of cysteine during drug delivery and can be used in disulfidptosis studies .
|
-
-
- HY-B0215S
-
|
Acetylcysteine-d3 is the deuterium labeled Acetylcysteine. Acetylcysteine (N-Acetylcysteine) is a mucolytic agent which reduces the thickness of the mucus. Acetylcysteine is a ROS inhibitor. Acetylcysteine is a cysteine precursor, prevents hemin-induced ferroptosis by neutralizing toxic lipids generated by arachidonate-dependent activity of 5-lipoxygenases. Acetylcysteine induces cell apoptosis. Acetylcysteine also has anti-influenza virus activities. In addition, Acetylcysteine is the most stable form of cysteine during drug delivery and can be used in disulfidptosis studies .
|
-
-
- HY-W721117
-
|
N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine-d3 (Methyl N-acetyl-S-(3-hydroxypropyl)-L-cysteinate-d3) is the deuterium labeled N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine.
|
-
-
- HY-19717S
-
|
DCVC- 13C3, 15N is 15N and 13C labeled DCVC. DCVC (S-[(1E)-1,2-Dichloroethenyl]-L-cysteine) is a bioactive metabolite of trichloroethylene (TCE). DCVC inhibits pathogen-stimulated pro-inflammatory cytokines IL-1β, IL-8, and TNF-α release from tissue cultures .
|
-
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: